13D/13G Filings - Bolt Biotherapeutics Inc. (BOLT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-17
4:56 pm
Purchase
2021-02-09 13D Bolt Biotherapeutics, Inc.
BOLT
Pivotal bioVenture Partners Fund I L.P. 1,891,467
5.500%
1,891,467increase
(New Position)
Filing
History
2021-02-16
2:14 pm
Purchase
2021-02-04 13D Bolt Biotherapeutics, Inc.
BOLT
Sofinnova Venture Partners X L.P. 2,754,437
8.000%
2,754,437increase
(New Position)
Filing
History
2021-02-11
4:36 pm
Purchase
2021-02-04 13D Bolt Biotherapeutics, Inc.
BOLT
Novo Holdings A/S 4,503,991
13.000%
4,503,991increase
(New Position)
Filing
History
Goto Prev, 0, 1